Kanamycin A is an antibiotic that belongs to the family of aminoglycosides. The antibiotic associates with ribosomal RNA by forming a complex at the bacterial ribosomal A site. Studies show that when Kanamycin A and Neomycin B (sc-338359) are conjugated through lipid conjugation there is an increase of antibacterial activity against methicillin-resistant Staphylococcus epidermidis (MRSE) from Kanamycin A and methicillin-resistant Staphylococcus aureus (MRSA) from both antibiotics.
1. Kwon, M., et al. 2001. Mol. Cells. 11: 303-311. PMID: 11459219
2. Balenci, D., et al. 2008. Chembiochem. 9: 114-123. PMID: 18058790
3. Bera, S., et al. 2010. J. Antimicrob. Chemother. 65: 1224-1227. PMID: 20332193
4. Xu, Y. et al. 2015. Anal. Chim. Acta. 891 : 298-303. PMID: 26388390
See how others have used Kanamycin A. Click on the entry to view the PubMed entry .
PMID: # 27236014 Pignatello, R. et al. 2016. Eur J Med Chem. 120: 329-37.
PMID: # 23224340 Shoae-Hassani, A. et al. 2013. Archivum immunologiae et therapiae experimentalis. 61: 75-83.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.